Patent intelligence · EP
EP 1028755
VERFAHREN ZUR REDUKTION VON OXYGENIERTEN RHENIUM ODER TECHNETIUM VERBINDUNGEN
VERFAHREN ZUR REDUKTION VON OXYGENIERTEN RHENIUM ODER TECHNETIUM VERBINDUNGEN
Patent details — EP 1028755
- Jurisdiction
- EP
- Status
- expired
- Grant date
- Aug 23, 2000
- Expiration
- Aug 18, 2020
- Applicant
- NYCOMED AMERSHAM SORIN S R L [IT]
- CPC classes
- A61K 51/ 00 A I, A61K 51/ 04 A I, A61K/510478, A61K51/04
Quick answer
EP 1028755 (VERFAHREN ZUR REDUKTION VON OXYGENIERTEN RHENIUM ODER TECHNETIUM VERBINDUNGEN) is held by NYCOMED AMERSHAM SORIN S R L [IT]. Status: expired. Granted Aug 23, 2000. Expires Aug 18, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- NYCOMED AMERSHAM SORIN S R L [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 51/ 00 A I, A61K 51/ 04 A I, A61K/510478, A61K51/04
More from NYCOMED AMERSHAM SORIN S R L [IT]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 1028755?
EP 1028755 (VERFAHREN ZUR REDUKTION VON OXYGENIERTEN RHENIUM ODER TECHNETIUM VERBINDUNGEN) is held by NYCOMED AMERSHAM SORIN S R L [IT]. Status: expired. Granted Aug 23, 2000. Expires Aug 18, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns EP 1028755?
NYCOMED AMERSHAM SORIN S R L [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does EP 1028755 expire?
Our index shows an expiration date of Aug 18, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.